Your browser doesn't support javascript.
loading
Seroprevalence, distribution, and risk factors for human leptospirosis in the United States Virgin Islands.
Artus, Aileen; Schafer, Ilana J; Cossaboom, Caitlin M; Haberling, Dana L; Galloway, Renee; Sutherland, Graham; Browne, A Springer; Roth, Joseph; France, Valicia; Cranford, Hannah M; Kines, Kristine J; Pompey, Justine; Ellis, Brett R; Walke, Henry; Ellis, Esther M.
Affiliation
  • Artus A; Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Schafer IJ; Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Cossaboom CM; Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Haberling DL; Epidemic Intelligence Service, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Galloway R; Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Sutherland G; Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Browne AS; Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Roth J; Epidemic Intelligence Service, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • France V; U.S. Virgin Islands Department of Health, U.S. Virgin Islands, United States of America.
  • Cranford HM; U.S. Virgin Islands Department of Health, U.S. Virgin Islands, United States of America.
  • Kines KJ; Division of Local and State Readiness, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Pompey J; U.S. Virgin Islands Department of Health, U.S. Virgin Islands, United States of America.
  • Ellis BR; U.S. Virgin Islands Department of Health, U.S. Virgin Islands, United States of America.
  • Walke H; Division of Preparedness and Emerging Infections, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Ellis EM; Division of Preparedness and Emerging Infections, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
PLoS Negl Trop Dis ; 16(11): e0010880, 2022 11.
Article in En | MEDLINE | ID: mdl-36378681
BACKGROUND: The first documented human leptospirosis cases in the U.S. Virgin Islands (USVI) occurred following 2017 Hurricanes Irma and Maria. We conducted a representative serosurvey in USVI to estimate the seroprevalence and distribution of human leptospirosis and evaluate local risk factors associated with seropositivity. METHODOLOGY/PRINCIPAL FINDINGS: A stratified, two-stage cluster sampling design was used and consisted of three island strata and random selection of census blocks and then households. All eligible members of selected households were invited to participate (≥5 years old, resided in USVI ≥6 months and ≥6 months/year). Household and individual-level questionnaires were completed, and serum collected from each enrolled individual. Microscopic agglutination test serology was conducted, and bivariate and logistic regression analyses completed to identify risk factors for seropositivity. In March 2019, 1,161 individuals were enrolled from 918 households in St. Croix, St. Thomas, and St. John. The territory-wide weighted seroprevalence was 4.0% (95% CI:2.3-5.7). Characteristics/exposures independently associated with seropositivity using logistic regression included contact with cows (OR: 39.5; 95% CI: 9.0-172.7), seeing rodents/rodent evidence or contact with rodents (OR: 2.6; 95% CI: 1.1-5.9), and increasing age (OR: 1.02; 95% CI: 1.002-1.04); full or partial Caucasian/White race was negatively correlated with seropositivity (OR: 0.02, 95% CI: 0.04-0.7). Bivariate analysis showed self-reported jaundice since the 2017 hurricanes (pRR: 5.7; 95% CI: 1.0-33.4) was associated with seropositivity and using a cover/lid on cisterns/rainwater collection containers (pRR: 0.3; 95% CI: 0.08-0.8) was protective against seropositivity. CONCLUSIONS/SIGNIFICANCE: Leptospirosis seropositivity of 4% across USVI demonstrates an important human disease that was previously unrecognized and emphasizes the importance of continued leptospirosis surveillance and investigation. Local risk factors identified may help guide future human and animal leptospirosis studies in USVI, strengthen leptospirosis public health surveillance and treatment timeliness, and inform targeted education, prevention, and control efforts.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leptospirosis Type of study: Etiology_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limits: Animals / Child, preschool / Female / Humans Country/Region as subject: Caribe / Caribe ingles / Islas virgenes de los estados unidos Language: En Journal: PLoS Negl Trop Dis Journal subject: MEDICINA TROPICAL Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leptospirosis Type of study: Etiology_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limits: Animals / Child, preschool / Female / Humans Country/Region as subject: Caribe / Caribe ingles / Islas virgenes de los estados unidos Language: En Journal: PLoS Negl Trop Dis Journal subject: MEDICINA TROPICAL Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States